Astellas Pharma Inc.
ALPMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1 | $68 | $75 | -$98 |
| Dep. & Amort. | $0 | $48 | $48 | $51 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1 | -$47 | -$22 | -$72 |
| Other Non-Cash | $0 | -$69 | $1 | $135 |
| Operating Cash Flow | $2 | $55 | $101 | $16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$13 | -$10 | $2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $13 | $7 | -$33 |
| Investing Cash Flow | -$0 | -$0 | -$3 | -$31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$10 | -$24 | -$16 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | -$1 | -$0 | -$0 |
| Dividends Paid | $0 | -$66 | $0 | -$66 |
| Other Fin. Act. | $0 | $77 | -$67 | -$22 |
| Financing Cash Flow | -$1 | -$0 | -$91 | -$104 |
| Forex Effect | -$0 | $0 | $1 | $6 |
| Net Chg. in Cash | $0 | $215 | $9 | $180 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $0 | $180 | $0 |
| End Cash | $2 | $215 | $188 | $180 |
| Free Cash Flow | $1 | $42 | $91 | $18 |